<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lanthanides-Based Nanoparticles Conjugated with Rose Bengal for FRET-Mediated X-Ray-Induced PDT - Health AI Hub</title>
    <meta name="description" content="This paper presents the development of lanthanide-based AGuIX nanoparticles conjugated with Rose Bengal (AGuIX Ln@RB) for F{√∂}rster Resonance Energy Transfer (F">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Lanthanides-Based Nanoparticles Conjugated with Rose Bengal for FRET-Mediated X-Ray-Induced PDT</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.10116v1" target="_blank">2511.10116v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-13
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Batoul Dhaini, Jo√´l Daouk, Herv√© Schohn, Philippe Arnoux, Val√©rie Jouan-Hureaux, Albert Moussaron, Agn√®s Hagege, Mathilde Achard, Samir Acherar, Tayssir Hamieh, C√©line Frochot
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.med-ph, cond-mat.mtrl-sci
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.10116v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.10116v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper presents the development of lanthanide-based AGuIX nanoparticles conjugated with Rose Bengal (AGuIX Ln@RB) for F{√∂}rster Resonance Energy Transfer (FRET)-mediated X-ray-induced photodynamic therapy (X-PDT) against cancer. The research optimized FRET efficiency, demonstrated X-ray-induced singlet oxygen production, achieved significant glioblastoma cell death in vitro, and showed successful conjugation of a cancer-targeting peptide, addressing the critical challenge of treating deep-seated tumors with PDT.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research offers a significant advancement in cancer therapy by enabling X-ray activation of photodynamic therapy, thereby allowing the treatment of deep-seated tumors like glioblastoma that are currently inaccessible to conventional light-based PDT. This innovation bypasses a major limitation in cancer treatment, broadening the applicability and effectiveness of PDT.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper describes experimental wet-lab research for therapeutic development and does not involve AI, machine learning, or computational models for health applications.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>AGuIX Ln@RB nanoparticles were synthesized for FRET-mediated X-PDT, aiming to overcome the poor tissue penetration of visible light in conventional PDT.</li>
                    
                    <li>Energy transfer between Terbium (Tb) or Gadolinium (Gd) (scintillators/donors) and Rose Bengal (RB, photosensitizer/acceptor) was optimized, proving to be FRET-like.</li>
                    
                    <li>The use of a spacer arm between the AGuIX core and Rose Bengal (AGuIX Ln@spacer arm-RB) significantly increased FRET efficiency.</li>
                    
                    <li>The nanoparticles demonstrated effective singlet oxygen production under both UV-visible illumination and therapeutically relevant X-ray irradiation.</li>
                    
                    <li>In vitro bioassays showed 52% cell death in U-251MG human malignant glioblastoma multiforme cells at 1 ¬µM RB concentration after X-ray irradiation (2 Gy).</li>
                    
                    <li>A NRP-1-targeting peptide (K(RB)DKPPR) was successfully conjugated onto AGuIX NPs via thiol-maleimide click chemistry, exhibiting nM range affinity for targeted delivery.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study involved the synthesis of lanthanide (Tb, Gd)-based AGuIX nanoparticles conjugated with Rose Bengal, both directly and via a spacer arm. FRET efficiency was studied by analyzing energy transfer between scintillators (donors) and RB (acceptor) in solution and on NPs. Singlet oxygen production was measured under UV-visible and X-ray irradiation. In vitro cytotoxicity was assessed using U-251MG glioblastoma cells after X-ray exposure. Finally, an NRP-1-targeting peptide was conjugated to the nanoparticles via thiol-maleimide click chemistry, and its binding affinity was determined.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The synthesized AGuIX Ln@RB nanoparticles successfully demonstrated FRET-like energy transfer, which was enhanced by a spacer arm. They effectively generated cytotoxic singlet oxygen upon X-ray irradiation, leading to a significant 52% cell death in glioblastoma cells at a low concentration (1 ¬µM RB) under a clinically relevant X-ray dose (2 Gy). Furthermore, the nanoparticles were successfully functionalized with an NRP-1-targeting peptide, showing high-affinity binding suitable for targeted cancer therapy.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This technology holds immense potential for the clinical treatment of deeply located and aggressive cancers, such as glioblastoma, by enabling non-invasive X-ray-activated photodynamic therapy. It offers a solution to the light penetration depth problem inherent in traditional PDT and, with targeted delivery, promises improved therapeutic efficacy and reduced systemic toxicity, potentially leading to more effective and safer cancer treatments.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly mentioned in the abstract. However, typical limitations for early-stage research like this would include the need for comprehensive in vivo efficacy and safety studies, detailed pharmacokinetic and biodistribution assessments, and optimization of dosage and X-ray parameters in preclinical models.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not explicitly mentioned in the abstract. However, the successful development of targeted nanoparticles strongly suggests that future research would focus on comprehensive in vivo studies to evaluate tumor regression, systemic toxicity, and pharmacokinetics in animal models. Further optimization of targeting strategies and X-ray delivery parameters for clinical translation would also be critical.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Radiotherapy</span>
                    
                    <span class="tag">Neuro-oncology</span>
                    
                    <span class="tag">Photodynamic Therapy</span>
                    
                    <span class="tag">Nanomedicine</span>
                    
                    <span class="tag">Medical Physics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">X-ray-induced Photodynamic Therapy</span>
                    
                    <span class="tag tag-keyword">FRET</span>
                    
                    <span class="tag tag-keyword">Lanthanide Nanoparticles</span>
                    
                    <span class="tag tag-keyword">AGuIX</span>
                    
                    <span class="tag tag-keyword">Rose Bengal</span>
                    
                    <span class="tag tag-keyword">Glioblastoma</span>
                    
                    <span class="tag tag-keyword">Singlet Oxygen</span>
                    
                    <span class="tag tag-keyword">Cancer Targeting</span>
                    
                    <span class="tag tag-keyword">Nanomedicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">In order to find a good candidate for F{√∂}rster Resonance Energy Transfer (FRET)-mediated X-ray-induced photodynamic therapy (X-PDT) for the treatment of cancer, lanthanide (Ln)-based AGuIX nanoparticles (NPs) conjugated with Rose Bengal (RB) as a photosensitizer (PS) were synthesized. X-PDT overcomes the problem of the poor penetration of visible light into tissues, which limits the efficacy of PDT in the treatment of deep-seated tumors. It is essential to optimize FRET efficiency by maximizing the overlap integral between donor emission and acceptor absorption and lengthening the duration of the donor emission. In this study, we optimized energy transfer between a scintillator (Sc) as a donor and a PS as an acceptor. Terbium (Tb) and Gadolinium (Gd) as Scs and Rose RB as a PS were chosen. The study of energy transfer between Tb, Gd and RB in solution and chelated on AGuIX NPs proved to be FRET-like. RB was conjugated directly onto AGuIX NPs (i.e., AGuIX Ln@RB), and the use of a spacer arm (i.e., AGuIX Ln@spacer arm-RB) increased FRET efficiency. Singlet oxygen production by these NPs was observed under UV--visible illumination and X-ray irradiation. The in vitro bioassay demonstrated 52% cell death of U-251MG derived from human malignant glioblastoma multiforme at a concentration of 1 $Œº$M RB after illumination and irradiation (2 Gy, 320 kV, 10 mA, 3 Gy/min at 47 cm). In addition, the RB-coupled NRP-1-targeting peptide (i.e., K(RB)DKPPR) was conjugated onto AGuIX NPs by a thiol-maleimide click chemistry reaction, and an affinity in the nM range was observed.</p>
            </section>

            

            
            <section class="paper-section">
                <h2>Journal Reference</h2>
                <p>Pharmaceuticals, 2025, 18 (5), pp.672</p>
            </section>
            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>